YC.png
StartX.png

GEn1E Lifesciences

 

PIPELINE

GEn1E has a pipeline of programs with strong preclinical data. Our lead program is a selective p38α kinase inhibitor, representing a platform for the treatment of various inflammatory and age-related diseases.

Who WE ARE

GEn1E’s team includes like-minded professionals with deep experience in Business Development and Strategy, Chemistry, Clinical, Formulations, CMC, Toxicology, Regulatory, Bio-Statistics, PK/ADME, Bioanalytical, IP Law and Health Economics.